Discover how a 56-year-old patient with BRCA2-positive ovarian cancer navigated neoadjuvant chemo, interval debulking, and PARP inhibitor therapy—ultimately facing therapy-related AML and a tragic outcome.
A Complex Fight: From Initial Complete Response to Recurrence and Therapy-Related AML Read More »
Discover how an 82-year-old with stage IIIC ovarian cancer fought recurrence using cytoreductive surgery, combination chemotherapy, and bevacizumab, gaining temporary remission before ultimately succumbing to her disease in 2009.
Overcoming Recurrent Ovarian Cancer: A Legacy of Hope at 82 Read More »
Discover how one patient with stage IIIC high-grade serous ovarian cancer achieved complete surgical resection via robotic techniques, completed carboplatin-paclitaxel therapy, and remains cancer-free on PARP maintenance 27 months later.
How One Patient Overcame Hidden Metastases and Now Thrives on Maintenance PARP Therapy Read More »
Discover how a 64-year-old patient with advanced, BRCA1/2 wild-type ovarian cancer overcame recurrence through surgical debulking, platinum re-challenge, and targeted rucaparib maintenance therapy.
Battling Advanced Ovarian Cancer: A 64-Year-Old’s Path to Targeted Maintenance Read More »
Discover how a BRCA1/2-negative Stage IIIC HGSC ovarian cancer patient overcame multiple brain metastases with surgery, targeted radiotherapy, and olaparib maintenance—remaining disease-free 63 months after diagnosis.
Defying Stage IIIC Ovarian Cancer: One Patient’s 63-Month Triumph Read More »
Discover how one 74-year-old patient with BRCA2-mutated Stage IVB ovarian cancer achieved 57 months of survival and avoided brain metastasis recurrence through gamma knife radiotherapy, targeted chemotherapy, and PARP inhibition.
Triumph Over Advanced HGSC: A 74-Year-Old’s 57-Month Survival Story Read More »
A second chance after a devastating stage 4 lung cancer diagnosis: Discover how Andrea R. regained hope through immunotherapy and the dedicated care of her medical team.
Finding Light in the Darkest Hour: A Busy Mom’s Stage IV Lung Cancer Miracle Read More »
A 53-year-old named Laurent was diagnosed with stage 4 lung cancer in June 2018. After immunotherapy and chemotherapy, he is now nearly in complete remission—proof that hope and advanced treatments can make all the difference.
Finding Hope and Strength: Laurent’s Triumph Over Stage IV Lung Cancer Read More »
Tejas P., MD, Assistant Professor, Medicine-Medical Oncology, University of Colorado Anschutz Medical Campus, and lung cancer survivor Lysa B. discuss how targeted therapy for ROS1-positive lung cancer offers hope and a better quality of life.
Rewriting the Rules: 12 Years of Targeted Therapy for Lysa’s Rare Lung Cancer Read More »
“There is much more hope.” These words from a 9+ year stage IV NSCLC survivor resonate deeply. Her journey, marked by multiple recurrences and triumphs, showcases the remarkable advancements in lung cancer treatment and the power of personalized medicine
Thriving 9½ Years with Recurrences – “Winning” with New Treatments Read More »
